nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TOP2A—Mitoxantrone—multiple sclerosis	0.17	0.196	CbGbCtD
Podofilox—NR3C1—Methylprednisolone—multiple sclerosis	0.134	0.155	CbGbCtD
Podofilox—NR3C1—Triamcinolone—multiple sclerosis	0.101	0.117	CbGbCtD
Podofilox—NR3C1—Betamethasone—multiple sclerosis	0.087	0.1	CbGbCtD
Podofilox—NR3C1—Prednisolone—multiple sclerosis	0.0858	0.0991	CbGbCtD
Podofilox—NR3C1—Prednisone—multiple sclerosis	0.0811	0.0936	CbGbCtD
Podofilox—NR3C1—Dexamethasone—multiple sclerosis	0.0506	0.0584	CbGbCtD
Podofilox—CYP3A4—Fingolimod—multiple sclerosis	0.029	0.0335	CbGbCtD
Podofilox—CYP2C19—Prednisone—multiple sclerosis	0.0234	0.027	CbGbCtD
Podofilox—CYP3A4—Methylprednisolone—multiple sclerosis	0.0187	0.0216	CbGbCtD
Podofilox—CYP2C19—Dexamethasone—multiple sclerosis	0.0146	0.0169	CbGbCtD
Podofilox—CYP3A4—Triamcinolone—multiple sclerosis	0.0141	0.0163	CbGbCtD
Podofilox—CYP3A4—Mitoxantrone—multiple sclerosis	0.0136	0.0157	CbGbCtD
Podofilox—CYP3A4—Betamethasone—multiple sclerosis	0.0121	0.014	CbGbCtD
Podofilox—CYP3A4—Prednisolone—multiple sclerosis	0.012	0.0138	CbGbCtD
Podofilox—CYP3A4—Prednisone—multiple sclerosis	0.0113	0.0131	CbGbCtD
Podofilox—TUBA4A—pineal body—multiple sclerosis	0.0078	0.231	CbGeAlD
Podofilox—CYP3A4—Dexamethasone—multiple sclerosis	0.00706	0.00816	CbGbCtD
Podofilox—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00294	0.0357	CcSEcCtD
Podofilox—Excoriation—Triamcinolone—multiple sclerosis	0.00262	0.0318	CcSEcCtD
Podofilox—TUBA4A—brainstem—multiple sclerosis	0.00243	0.0722	CbGeAlD
Podofilox—Redness—Cladribine—multiple sclerosis	0.00237	0.0287	CcSEcCtD
Podofilox—TUBA4A—retina—multiple sclerosis	0.00235	0.0697	CbGeAlD
Podofilox—NR3C1—nerve—multiple sclerosis	0.00192	0.0571	CbGeAlD
Podofilox—TUBA4A—medulla oblongata—multiple sclerosis	0.0017	0.0503	CbGeAlD
Podofilox—Inflammation—Cladribine—multiple sclerosis	0.00165	0.02	CcSEcCtD
Podofilox—TUBB—Azacitidine—Cladribine—multiple sclerosis	0.00158	0.382	CbGdCrCtD
Podofilox—TUBA4A—midbrain—multiple sclerosis	0.00155	0.046	CbGeAlD
Podofilox—TUBA4A—spinal cord—multiple sclerosis	0.00151	0.0449	CbGeAlD
Podofilox—Swelling—Cladribine—multiple sclerosis	0.00131	0.016	CcSEcCtD
Podofilox—TUBA4A—nervous system—multiple sclerosis	0.00127	0.0378	CbGeAlD
Podofilox—TUBB—medulla oblongata—multiple sclerosis	0.00124	0.0369	CbGeAlD
Podofilox—TUBA4A—central nervous system—multiple sclerosis	0.00123	0.0364	CbGeAlD
Podofilox—TUBA4A—cerebellum—multiple sclerosis	0.0012	0.0356	CbGeAlD
Podofilox—Blister—Prednisolone—multiple sclerosis	0.00119	0.0145	CcSEcCtD
Podofilox—TUBB—midbrain—multiple sclerosis	0.00114	0.0337	CbGeAlD
Podofilox—Ulcer—Mitoxantrone—multiple sclerosis	0.00111	0.0135	CcSEcCtD
Podofilox—TUBB—spinal cord—multiple sclerosis	0.00111	0.0329	CbGeAlD
Podofilox—Blister—Triamcinolone—multiple sclerosis	0.0011	0.0133	CcSEcCtD
Podofilox—Stinging—Prednisolone—multiple sclerosis	0.00106	0.0129	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00104	0.0126	CcSEcCtD
Podofilox—Blister—Dexamethasone—multiple sclerosis	0.000997	0.0121	CcSEcCtD
Podofilox—Blister—Betamethasone—multiple sclerosis	0.000997	0.0121	CcSEcCtD
Podofilox—Tingling sensation—Methylprednisolone—multiple sclerosis	0.000983	0.0119	CcSEcCtD
Podofilox—Stinging—Triamcinolone—multiple sclerosis	0.000978	0.0119	CcSEcCtD
Podofilox—Skin disorder—Fingolimod—multiple sclerosis	0.000976	0.0119	CcSEcCtD
Podofilox—TUBA4A—brain—multiple sclerosis	0.000974	0.0289	CbGeAlD
Podofilox—TOP2A—Floxuridine—Cladribine—multiple sclerosis	0.000969	0.234	CbGdCrCtD
Podofilox—Paraesthesia—Fingolimod—multiple sclerosis	0.000903	0.011	CcSEcCtD
Podofilox—Tingling sensation—Dexamethasone—multiple sclerosis	0.000894	0.0109	CcSEcCtD
Podofilox—Tingling sensation—Betamethasone—multiple sclerosis	0.000894	0.0109	CcSEcCtD
Podofilox—Stinging—Dexamethasone—multiple sclerosis	0.000887	0.0108	CcSEcCtD
Podofilox—Stinging—Betamethasone—multiple sclerosis	0.000887	0.0108	CcSEcCtD
Podofilox—TUBB—cerebellum—multiple sclerosis	0.000879	0.0261	CbGeAlD
Podofilox—Swelling—Mitoxantrone—multiple sclerosis	0.000864	0.0105	CcSEcCtD
Podofilox—Ulcer—Triamcinolone—multiple sclerosis	0.000837	0.0102	CcSEcCtD
Podofilox—NR3C1—brainstem—multiple sclerosis	0.000826	0.0245	CbGeAlD
Podofilox—Inflammation—Methylprednisolone—multiple sclerosis	0.000815	0.00989	CcSEcCtD
Podofilox—Haemoglobin—Cladribine—multiple sclerosis	0.000806	0.00979	CcSEcCtD
Podofilox—Haemorrhage—Cladribine—multiple sclerosis	0.000802	0.00974	CcSEcCtD
Podofilox—Ulcer—Dexamethasone—multiple sclerosis	0.00076	0.00923	CcSEcCtD
Podofilox—Ulcer—Betamethasone—multiple sclerosis	0.00076	0.00923	CcSEcCtD
Podofilox—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000756	0.00918	CcSEcCtD
Podofilox—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000754	0.00916	CcSEcCtD
Podofilox—Immune system disorder—Cladribine—multiple sclerosis	0.000724	0.0088	CcSEcCtD
Podofilox—TUBB—brain—multiple sclerosis	0.000714	0.0212	CbGeAlD
Podofilox—Pruritus—Fingolimod—multiple sclerosis	0.000711	0.00864	CcSEcCtD
Podofilox—Erythema—Cladribine—multiple sclerosis	0.000698	0.00848	CcSEcCtD
Podofilox—Skin exfoliation—Betamethasone—multiple sclerosis	0.000686	0.00833	CcSEcCtD
Podofilox—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000686	0.00833	CcSEcCtD
Podofilox—TOP2A—Clofarabine—Cladribine—multiple sclerosis	0.000678	0.164	CbGdCrCtD
Podofilox—Skin ulcer—Methotrexate—multiple sclerosis	0.000672	0.00816	CcSEcCtD
Podofilox—Dizziness—Fingolimod—multiple sclerosis	0.000665	0.00807	CcSEcCtD
Podofilox—Ulcer—Prednisone—multiple sclerosis	0.000662	0.00803	CcSEcCtD
Podofilox—Haemoglobin—Azathioprine—multiple sclerosis	0.000655	0.00796	CcSEcCtD
Podofilox—Dermatitis bullous—Prednisolone—multiple sclerosis	0.000654	0.00794	CcSEcCtD
Podofilox—Haemorrhage—Azathioprine—multiple sclerosis	0.000652	0.00792	CcSEcCtD
Podofilox—Headache—Fingolimod—multiple sclerosis	0.00063	0.00765	CcSEcCtD
Podofilox—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.000602	0.0073	CcSEcCtD
Podofilox—Skin exfoliation—Prednisone—multiple sclerosis	0.000598	0.00726	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00059	0.00717	CcSEcCtD
Podofilox—Immune system disorder—Azathioprine—multiple sclerosis	0.000589	0.00715	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—PLEK—multiple sclerosis	0.000585	0.0413	CbGpPWpGaD
Podofilox—Skin discolouration—Methotrexate—multiple sclerosis	0.000579	0.00703	CcSEcCtD
Podofilox—NR3C1—medulla oblongata—multiple sclerosis	0.000576	0.0171	CbGeAlD
Podofilox—Dry skin—Prednisolone—multiple sclerosis	0.000573	0.00696	CcSEcCtD
Podofilox—Oedema—Cladribine—multiple sclerosis	0.00057	0.00692	CcSEcCtD
Podofilox—Haematuria—Mitoxantrone—multiple sclerosis	0.00056	0.0068	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000557	0.0394	CbGpPWpGaD
Podofilox—Skin disorder—Cladribine—multiple sclerosis	0.000553	0.00672	CcSEcCtD
Podofilox—Ulcer—Methotrexate—multiple sclerosis	0.000553	0.00671	CcSEcCtD
Podofilox—Dermatitis bullous—Betamethasone—multiple sclerosis	0.000546	0.00663	CcSEcCtD
Podofilox—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.000546	0.00663	CcSEcCtD
Podofilox—Inflammation—Methotrexate—multiple sclerosis	0.000539	0.00655	CcSEcCtD
Podofilox—Haemoglobin—Mitoxantrone—multiple sclerosis	0.00053	0.00643	CcSEcCtD
Podofilox—Haemorrhage—Mitoxantrone—multiple sclerosis	0.000527	0.0064	CcSEcCtD
Podofilox—NR3C1—midbrain—multiple sclerosis	0.000526	0.0156	CbGeAlD
Podofilox—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000518	0.0366	CbGpPWpGaD
Podofilox—Insomnia—Cladribine—multiple sclerosis	0.000515	0.00626	CcSEcCtD
Podofilox—NR3C1—spinal cord—multiple sclerosis	0.000513	0.0152	CbGeAlD
Podofilox—Paraesthesia—Cladribine—multiple sclerosis	0.000512	0.00621	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—multiple sclerosis	0.000499	0.00606	CcSEcCtD
Podofilox—Pain—Cladribine—multiple sclerosis	0.000487	0.00592	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00048	0.00583	CcSEcCtD
Podofilox—Dry skin—Dexamethasone—multiple sclerosis	0.000478	0.00581	CcSEcCtD
Podofilox—Dry skin—Betamethasone—multiple sclerosis	0.000478	0.00581	CcSEcCtD
Podofilox—Erythema—Mitoxantrone—multiple sclerosis	0.000459	0.00557	CcSEcCtD
Podofilox—Skin disorder—Azathioprine—multiple sclerosis	0.00045	0.00546	CcSEcCtD
Podofilox—Haemoglobin—Prednisolone—multiple sclerosis	0.000435	0.00528	CcSEcCtD
Podofilox—NR3C1—nervous system—multiple sclerosis	0.000433	0.0128	CbGeAlD
Podofilox—Haemorrhage—Prednisolone—multiple sclerosis	0.000433	0.00525	CcSEcCtD
Podofilox—NR3C1—central nervous system—multiple sclerosis	0.000417	0.0124	CbGeAlD
Podofilox—Dry skin—Prednisone—multiple sclerosis	0.000416	0.00506	CcSEcCtD
Podofilox—TOP2A—Azacitidine—Cladribine—multiple sclerosis	0.000414	0.0998	CbGdCrCtD
Podofilox—NR3C1—cerebellum—multiple sclerosis	0.000407	0.0121	CbGeAlD
Podofilox—Pruritus—Cladribine—multiple sclerosis	0.000403	0.0049	CcSEcCtD
Podofilox—Haemoglobin—Triamcinolone—multiple sclerosis	0.0004	0.00485	CcSEcCtD
Podofilox—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000399	0.00484	CcSEcCtD
Podofilox—Haemorrhage—Triamcinolone—multiple sclerosis	0.000398	0.00483	CcSEcCtD
Podofilox—Haemorrhage—Methylprednisolone—multiple sclerosis	0.000397	0.00482	CcSEcCtD
Podofilox—Dizziness—Cladribine—multiple sclerosis	0.000377	0.00458	CcSEcCtD
Podofilox—Erythema—Prednisolone—multiple sclerosis	0.000377	0.00457	CcSEcCtD
Podofilox—Oedema—Mitoxantrone—multiple sclerosis	0.000375	0.00455	CcSEcCtD
Podofilox—Skin disorder—Mitoxantrone—multiple sclerosis	0.000364	0.00442	CcSEcCtD
Podofilox—Haemoglobin—Dexamethasone—multiple sclerosis	0.000363	0.0044	CcSEcCtD
Podofilox—Haemoglobin—Betamethasone—multiple sclerosis	0.000363	0.0044	CcSEcCtD
Podofilox—Vomiting—Cladribine—multiple sclerosis	0.000362	0.0044	CcSEcCtD
Podofilox—Haemorrhage—Betamethasone—multiple sclerosis	0.000361	0.00438	CcSEcCtD
Podofilox—Haemorrhage—Dexamethasone—multiple sclerosis	0.000361	0.00438	CcSEcCtD
Podofilox—Rash—Cladribine—multiple sclerosis	0.000359	0.00436	CcSEcCtD
Podofilox—Dermatitis—Cladribine—multiple sclerosis	0.000359	0.00436	CcSEcCtD
Podofilox—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000358	0.00435	CcSEcCtD
Podofilox—Headache—Cladribine—multiple sclerosis	0.000357	0.00433	CcSEcCtD
Podofilox—Erythema—Triamcinolone—multiple sclerosis	0.000346	0.0042	CcSEcCtD
Podofilox—Erythema—Methylprednisolone—multiple sclerosis	0.000345	0.0042	CcSEcCtD
Podofilox—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000336	0.00408	CcSEcCtD
Podofilox—NR3C1—brain—multiple sclerosis	0.000331	0.00982	CbGeAlD
Podofilox—CYP3A4—nervous system—multiple sclerosis	0.000327	0.00971	CbGeAlD
Podofilox—Pain—Mitoxantrone—multiple sclerosis	0.00032	0.00389	CcSEcCtD
Podofilox—Haemoglobin—Prednisone—multiple sclerosis	0.000316	0.00384	CcSEcCtD
Podofilox—CYP3A4—central nervous system—multiple sclerosis	0.000315	0.00935	CbGeAlD
Podofilox—Haemorrhage—Prednisone—multiple sclerosis	0.000314	0.00382	CcSEcCtD
Podofilox—Erythema—Betamethasone—multiple sclerosis	0.000314	0.00381	CcSEcCtD
Podofilox—Erythema—Dexamethasone—multiple sclerosis	0.000314	0.00381	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000314	0.0222	CbGpPWpGaD
Podofilox—Oedema—Prednisolone—multiple sclerosis	0.000307	0.00373	CcSEcCtD
Podofilox—Dizziness—Azathioprine—multiple sclerosis	0.000306	0.00372	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000302	0.0214	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.000298	0.021	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.000298	0.021	CbGpPWpGaD
Podofilox—Vomiting—Azathioprine—multiple sclerosis	0.000295	0.00358	CcSEcCtD
Podofilox—Rash—Azathioprine—multiple sclerosis	0.000292	0.00355	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000292	0.00355	CcSEcCtD
Podofilox—Dermatitis—Azathioprine—multiple sclerosis	0.000292	0.00354	CcSEcCtD
Podofilox—Headache—Azathioprine—multiple sclerosis	0.00029	0.00352	CcSEcCtD
Podofilox—Immune system disorder—Prednisone—multiple sclerosis	0.000284	0.00345	CcSEcCtD
Podofilox—Oedema—Triamcinolone—multiple sclerosis	0.000283	0.00343	CcSEcCtD
Podofilox—Haematuria—Methotrexate—multiple sclerosis	0.000279	0.00339	CcSEcCtD
Podofilox—Insomnia—Prednisolone—multiple sclerosis	0.000278	0.00337	CcSEcCtD
Podofilox—Paraesthesia—Prednisolone—multiple sclerosis	0.000276	0.00335	CcSEcCtD
Podofilox—Skin disorder—Methylprednisolone—multiple sclerosis	0.000274	0.00333	CcSEcCtD
Podofilox—Erythema—Prednisone—multiple sclerosis	0.000274	0.00332	CcSEcCtD
Podofilox—Haemoglobin—Methotrexate—multiple sclerosis	0.000264	0.00321	CcSEcCtD
Podofilox—Pain—Prednisolone—multiple sclerosis	0.000263	0.00319	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—multiple sclerosis	0.000263	0.00319	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000259	0.0183	CbGpPWpGaD
Podofilox—Oedema—Betamethasone—multiple sclerosis	0.000256	0.00311	CcSEcCtD
Podofilox—Oedema—Dexamethasone—multiple sclerosis	0.000256	0.00311	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.000256	0.0181	CbGpPWpGaD
Podofilox—Insomnia—Triamcinolone—multiple sclerosis	0.000256	0.0031	CcSEcCtD
Podofilox—Insomnia—Methylprednisolone—multiple sclerosis	0.000255	0.0031	CcSEcCtD
Podofilox—Paraesthesia—Triamcinolone—multiple sclerosis	0.000254	0.00308	CcSEcCtD
Podofilox—TOP2A—Methyltestosterone—Prednisone—multiple sclerosis	0.000253	0.0612	CbGdCrCtD
Podofilox—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000253	0.00307	CcSEcCtD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—TLR4—multiple sclerosis	0.000248	0.0175	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Prednisolone—multiple sclerosis	0.000247	0.0597	CbGdCrCtD
Podofilox—Pain—Triamcinolone—multiple sclerosis	0.000242	0.00293	CcSEcCtD
Podofilox—Vomiting—Mitoxantrone—multiple sclerosis	0.000238	0.00289	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—multiple sclerosis	0.000237	0.00288	CcSEcCtD
Podofilox—Rash—Mitoxantrone—multiple sclerosis	0.000236	0.00287	CcSEcCtD
Podofilox—Dermatitis—Mitoxantrone—multiple sclerosis	0.000236	0.00287	CcSEcCtD
Podofilox—Headache—Mitoxantrone—multiple sclerosis	0.000235	0.00285	CcSEcCtD
Podofilox—Insomnia—Dexamethasone—multiple sclerosis	0.000232	0.00282	CcSEcCtD
Podofilox—Insomnia—Betamethasone—multiple sclerosis	0.000232	0.00282	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000231	0.00281	CcSEcCtD
Podofilox—Paraesthesia—Dexamethasone—multiple sclerosis	0.00023	0.0028	CcSEcCtD
Podofilox—Paraesthesia—Betamethasone—multiple sclerosis	0.00023	0.0028	CcSEcCtD
Podofilox—Erythema—Methotrexate—multiple sclerosis	0.000229	0.00278	CcSEcCtD
Podofilox—Oedema—Prednisone—multiple sclerosis	0.000223	0.00271	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	0.000222	0.0157	CbGpPWpGaD
Podofilox—Pain—Dexamethasone—multiple sclerosis	0.000219	0.00266	CcSEcCtD
Podofilox—Pain—Betamethasone—multiple sclerosis	0.000219	0.00266	CcSEcCtD
Podofilox—Skin disorder—Prednisone—multiple sclerosis	0.000217	0.00263	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—SELPLG—multiple sclerosis	0.000216	0.0153	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CD58—multiple sclerosis	0.000216	0.0153	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MERTK—multiple sclerosis	0.000216	0.0153	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—multiple sclerosis	0.000214	0.0151	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TLR4—multiple sclerosis	0.000211	0.0149	CbGpPWpGaD
Podofilox—Dizziness—Prednisolone—multiple sclerosis	0.000203	0.00247	CcSEcCtD
Podofilox—Insomnia—Prednisone—multiple sclerosis	0.000202	0.00245	CcSEcCtD
Podofilox—Paraesthesia—Prednisone—multiple sclerosis	0.0002	0.00243	CcSEcCtD
Podofilox—Pruritus—Triamcinolone—multiple sclerosis	0.0002	0.00243	CcSEcCtD
Podofilox—Pruritus—Methylprednisolone—multiple sclerosis	0.000199	0.00242	CcSEcCtD
Podofilox—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	0.000196	0.0139	CbGpPWpGaD
Podofilox—Rash—Prednisolone—multiple sclerosis	0.000194	0.00235	CcSEcCtD
Podofilox—Dermatitis—Prednisolone—multiple sclerosis	0.000194	0.00235	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000193	0.00235	CcSEcCtD
Podofilox—Headache—Prednisolone—multiple sclerosis	0.000192	0.00234	CcSEcCtD
Podofilox—Dizziness—Triamcinolone—multiple sclerosis	0.000187	0.00227	CcSEcCtD
Podofilox—Dizziness—Methylprednisolone—multiple sclerosis	0.000186	0.00226	CcSEcCtD
Podofilox—Pruritus—Dexamethasone—multiple sclerosis	0.000181	0.0022	CcSEcCtD
Podofilox—Pruritus—Betamethasone—multiple sclerosis	0.000181	0.0022	CcSEcCtD
Podofilox—Skin disorder—Methotrexate—multiple sclerosis	0.000181	0.0022	CcSEcCtD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000181	0.0128	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000181	0.0128	CbGpPWpGaD
Podofilox—Vomiting—Triamcinolone—multiple sclerosis	0.00018	0.00218	CcSEcCtD
Podofilox—Vomiting—Methylprednisolone—multiple sclerosis	0.000179	0.00218	CcSEcCtD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000179	0.0126	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000179	0.0126	CbGpPWpGaD
Podofilox—Rash—Triamcinolone—multiple sclerosis	0.000178	0.00216	CcSEcCtD
Podofilox—Dermatitis—Triamcinolone—multiple sclerosis	0.000178	0.00216	CcSEcCtD
Podofilox—Rash—Methylprednisolone—multiple sclerosis	0.000178	0.00216	CcSEcCtD
Podofilox—Dermatitis—Methylprednisolone—multiple sclerosis	0.000178	0.00216	CcSEcCtD
Podofilox—Headache—Triamcinolone—multiple sclerosis	0.000177	0.00215	CcSEcCtD
Podofilox—Headache—Methylprednisolone—multiple sclerosis	0.000177	0.00214	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000175	0.0124	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000172	0.0121	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000172	0.0121	CbGpPWpGaD
Podofilox—Dizziness—Dexamethasone—multiple sclerosis	0.00017	0.00206	CcSEcCtD
Podofilox—Dizziness—Betamethasone—multiple sclerosis	0.00017	0.00206	CcSEcCtD
Podofilox—Insomnia—Methotrexate—multiple sclerosis	0.000169	0.00205	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—multiple sclerosis	0.000168	0.00203	CcSEcCtD
Podofilox—Vomiting—Dexamethasone—multiple sclerosis	0.000163	0.00198	CcSEcCtD
Podofilox—Vomiting—Betamethasone—multiple sclerosis	0.000163	0.00198	CcSEcCtD
Podofilox—Rash—Betamethasone—multiple sclerosis	0.000162	0.00196	CcSEcCtD
Podofilox—Rash—Dexamethasone—multiple sclerosis	0.000162	0.00196	CcSEcCtD
Podofilox—Dermatitis—Dexamethasone—multiple sclerosis	0.000162	0.00196	CcSEcCtD
Podofilox—Dermatitis—Betamethasone—multiple sclerosis	0.000162	0.00196	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000161	0.0114	CbGpPWpGaD
Podofilox—Headache—Dexamethasone—multiple sclerosis	0.000161	0.00195	CcSEcCtD
Podofilox—Headache—Betamethasone—multiple sclerosis	0.000161	0.00195	CcSEcCtD
Podofilox—Pain—Methotrexate—multiple sclerosis	0.00016	0.00194	CcSEcCtD
Podofilox—Pruritus—Prednisone—multiple sclerosis	0.000158	0.00192	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	0.000155	0.011	CbGpPWpGaD
Podofilox—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000152	0.0107	CbGpPWpGaD
Podofilox—Dizziness—Prednisone—multiple sclerosis	0.000148	0.00179	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	0.000147	0.0104	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—ALB—multiple sclerosis	0.000147	0.0104	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000147	0.0104	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000147	0.0104	CbGpPWpGaD
Podofilox—Vomiting—Prednisone—multiple sclerosis	0.000142	0.00172	CcSEcCtD
Podofilox—Rash—Prednisone—multiple sclerosis	0.000141	0.00171	CcSEcCtD
Podofilox—Dermatitis—Prednisone—multiple sclerosis	0.000141	0.00171	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—ALB—multiple sclerosis	0.00014	0.0099	CbGpPWpGaD
Podofilox—Headache—Prednisone—multiple sclerosis	0.00014	0.0017	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—PLEK—multiple sclerosis	0.000134	0.00945	CbGpPWpGaD
Podofilox—Pruritus—Methotrexate—multiple sclerosis	0.000132	0.0016	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00013	0.00921	CbGpPWpGaD
Podofilox—Dizziness—Methotrexate—multiple sclerosis	0.000123	0.0015	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000123	0.00866	CbGpPWpGaD
Podofilox—Vomiting—Methotrexate—multiple sclerosis	0.000119	0.00144	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—multiple sclerosis	0.000118	0.00837	CbGpPWpGaD
Podofilox—Rash—Methotrexate—multiple sclerosis	0.000118	0.00143	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—multiple sclerosis	0.000118	0.00143	CcSEcCtD
Podofilox—Headache—Methotrexate—multiple sclerosis	0.000117	0.00142	CcSEcCtD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000109	0.0077	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000109	0.0077	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000107	0.0076	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000107	0.0076	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000107	0.00754	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000105	0.00743	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	0.000105	0.00742	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.0001	0.0071	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	9.87e-05	0.00698	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	9.77e-05	0.00691	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SELE—multiple sclerosis	9.42e-05	0.00665	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—TGFB1—multiple sclerosis	9.3e-05	0.00657	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	9.26e-05	0.00654	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	9.02e-05	0.00638	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	9e-05	0.00636	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	8.89e-05	0.00628	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	8.86e-05	0.00626	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.83e-05	0.00624	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.83e-05	0.00624	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	8.83e-05	0.00624	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	8.65e-05	0.00611	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—PABPC1—multiple sclerosis	8.5e-05	0.00601	CbGpPWpGaD
Podofilox—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.48e-05	0.006	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	8.47e-05	0.00598	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	8.24e-05	0.00582	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	8.16e-05	0.00577	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	7.93e-05	0.00561	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	7.8e-05	0.00551	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	7.8e-05	0.00551	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.69e-05	0.00544	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.69e-05	0.00544	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—RPL5—multiple sclerosis	7.67e-05	0.00542	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	7.18e-05	0.00507	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	7.09e-05	0.00501	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ITGA4—multiple sclerosis	6.81e-05	0.00481	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IFNB1—multiple sclerosis	6.76e-05	0.00478	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	6.52e-05	0.00461	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	6.4e-05	0.00452	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	6.3e-05	0.00445	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.06e-05	0.00429	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—FAS—multiple sclerosis	5.82e-05	0.00411	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	5.76e-05	0.00407	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—BCHE—multiple sclerosis	5.61e-05	0.00397	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.61e-05	0.00397	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	5.44e-05	0.00385	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	5.29e-05	0.00374	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	5.19e-05	0.00366	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	5.11e-05	0.00361	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—FAS—multiple sclerosis	5.06e-05	0.00357	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	4.88e-05	0.00345	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	4.84e-05	0.00342	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ZNF746—multiple sclerosis	4.84e-05	0.00342	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	4.8e-05	0.00339	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.69e-05	0.00331	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.69e-05	0.00331	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2RA—multiple sclerosis	4.65e-05	0.00329	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.62e-05	0.00327	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.62e-05	0.00327	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	4.58e-05	0.00324	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PTBP1—multiple sclerosis	4.42e-05	0.00313	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	4.26e-05	0.00301	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	4.13e-05	0.00292	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.07e-05	0.00288	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	4.05e-05	0.00286	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	3.86e-05	0.00273	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	3.78e-05	0.00267	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	3.77e-05	0.00267	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—multiple sclerosis	3.65e-05	0.00258	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	3.37e-05	0.00238	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ALB—multiple sclerosis	3.36e-05	0.00238	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	3.35e-05	0.00237	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—U2AF2—multiple sclerosis	3.35e-05	0.00237	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.3e-05	0.00233	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	3.26e-05	0.0023	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	3.03e-05	0.00214	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.99e-05	0.00212	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.99e-05	0.00212	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—POMC—multiple sclerosis	2.9e-05	0.00205	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	2.84e-05	0.00201	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CCL2—multiple sclerosis	2.84e-05	0.00201	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.76e-05	0.00195	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.76e-05	0.00195	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—multiple sclerosis	2.73e-05	0.00193	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.7e-05	0.00191	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	2.65e-05	0.00187	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.57e-05	0.00182	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	2.56e-05	0.00181	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	2.5e-05	0.00177	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—STAT3—multiple sclerosis	2.48e-05	0.00175	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.45e-05	0.00173	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	2.3e-05	0.00162	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.25e-05	0.00159	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.2e-05	0.00156	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—multiple sclerosis	2.15e-05	0.00152	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—multiple sclerosis	2.13e-05	0.0015	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	2.12e-05	0.0015	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—MAPK1—multiple sclerosis	2.09e-05	0.00147	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PABPC1—multiple sclerosis	2.05e-05	0.00145	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—multiple sclerosis	2.01e-05	0.00142	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—multiple sclerosis	1.99e-05	0.00141	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.99e-05	0.0014	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MAPK1—multiple sclerosis	1.97e-05	0.00139	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.91e-05	0.00135	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SRM—multiple sclerosis	1.89e-05	0.00134	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.87e-05	0.00132	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.86e-05	0.00131	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL5—multiple sclerosis	1.85e-05	0.00131	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.75e-05	0.00124	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—multiple sclerosis	1.73e-05	0.00122	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—multiple sclerosis	1.71e-05	0.00121	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MAPK1—multiple sclerosis	1.67e-05	0.00118	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.5e-05	0.00106	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PGR—multiple sclerosis	1.46e-05	0.00103	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.34e-05	0.000946	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.33e-05	0.000942	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.33e-05	0.000942	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.31e-05	0.000925	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.3e-05	0.000921	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.22e-05	0.000862	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—multiple sclerosis	1.2e-05	0.000846	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MAPK1—multiple sclerosis	1.17e-05	0.000827	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SRM—multiple sclerosis	1.14e-05	0.000804	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.05e-05	0.000746	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—multiple sclerosis	1.02e-05	0.00072	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.01e-05	0.000714	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	8.42e-06	0.000595	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.02e-06	0.000567	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.02e-06	0.000567	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.84e-06	0.000554	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.33e-06	0.000518	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.74e-06	0.000476	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.14e-06	0.000434	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.08e-06	0.00043	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.8e-06	0.00041	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—multiple sclerosis	4.05e-06	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—APOE—multiple sclerosis	3.49e-06	0.000247	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.49e-06	0.000247	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—POMC—multiple sclerosis	3e-06	0.000212	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ALB—multiple sclerosis	2.73e-06	0.000193	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—APOE—multiple sclerosis	2.1e-06	0.000148	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—POMC—multiple sclerosis	1.8e-06	0.000127	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ALB—multiple sclerosis	1.64e-06	0.000116	CbGpPWpGaD
